Medwell Capital Corp.
- TSX Venture
- Consumer Products
- Latest 1.40
- Currency C$
- Change 0.0000
- Percent Change 0.00 %
- Volume 728
- Fri Dec 20, 2013 12:24 PM EST TSX Venture data delayed 15 minutes.
12 months ended Dec 31, 2011.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Nov 13||n/a||Feb 12||n/a|
12 months ended Dec 21, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
MEDWELL CAPITAL CORP. is a biotechnology company focused on the commercialization of DIRUCOTIDE for the treatment of multiple sclerosis (MS).